Daily Stock List
Rich Pharmaceuticals, Inc. (RCHA)
Greenbackers reported on Rich Pharmaceuticals, Inc. (RCHA), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Rich Pharmaceuticals, Inc. is a Biopharmaceutical Company based in Beverly Hills, California. It is developing a treatment for Acute Myelocytic Leukemia (AML)/white blood cell elevation and other blood related diseases. The Company is centering on the development of its lead product, RP-323 (12-O-tetradecanoylphorbol-13-acetate), for the treatment of acute myelogenous leukemia (AML) in refractory patients. Rich’s aim is to extend refractory patients life expectancy and increase quality of life. Rich Pharmaceuticals lists on the OTC Bulletin Board.
The design of the Company’s RP-323 is to treat blood and cancer related diseases via non-evasive outpatient facilities. On the whole, Rich Pharmaceuticals is focusing on the discovery, development, as well as commercialization of drugs to treat unmet medical needs in oncology that function at the DNA level. Its corporate mission is to develop these small-molecule compounds to treat cancer and stroke in patients with the greatest unmet medical needs.
Rich Pharmaceuticals has entered into an agreement with Richard L. Chang Holdings, LLC, headquartered in New Jersey, for ownership to its investigational cancer patent assignment using Phorbol Esters in the treatment of Hodgkin's Lymphoma. Hodgkin lymphoma is a cancer of the immune system, marked by the presence of a type of cell called the Reed-Sternberg cell. Currently, this disease affects greater than 100,000 patients annually.
With this agreement, Rich Pharmaceuticals will obtain complete ownership and all interest in the indication, patents, and intellectual property (IP) related to treatment of Hodgkin's Lymphoma, utility patent application number 61998397, entitled Compositions And Methods Of Use Of Phorbol Esters For The Treatment Of Hodgkin's Lymphoma.
Furthermore, Rich Pharmaceuticals recently announced that it submitted an investigational new drug (IND) application to conduct a Phase 2 clinical trial for its lead compound RP-323 in Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) with the U.S. Food and Drug Administration (FDA). Rich’s plan is to initiate a multicenter, Phase 2 clinical study using RP-323 to treat AML and MDS patients.
Rich Pharmaceuticals, Inc. (RCHA), closed Friday's trading session at $0.0012, down 7.69%, on 9,474,388 volume with 58 trades. The average volume for the last 60 days is 2,122,576 and the stock's 52-week low/high is $0.0011/$0.455.
FullCircle Registry, Inc. (FLCR)
We are reporting on FullCircle Registry, Inc. (FLCR) today, here at the QualityStocks Daily Newsletter.
FullCircle Registry, Inc. is an acquisition company that provides exit plans to successful profitable businesses in expanding business sectors. Its mission is to provide a home for those who have developed successful companies and have no exit capabilities. FullCircle Registry has opened up subsidiaries to be homes for the Company’s acquisitions. FullCircle Registry is based in Shelbyville, Kentucky.
The Company’s focus is to provide exit capabilities for small to medium sized private, profitable companies through acquisition, to improve its stockholder value while leaving those companies independent where possible to continue to be managed by the team that founded them, and then providing liquidity and greater returns for the founder(s).
Companies that FullCircle Registry owns include FullCircle Entertainment, Inc. and FullCircle Medical Supplies, Inc. Pertaining to FullCircle Entertainment, the Company purchased Georgetown 14 Cinemas in 2010. It operates in Indianapolis, Indiana. Concerning FullCircle Medical Supplies, the Company is in the process of acquiring a number of DME businesses to provide full state coverage for Louisiana.
FullCircle Registry announced last month that its S-1 Registration Statement filed with the Securities and Exchange Commission (SEC) became effective, securing a $1.5M financing commitment from Kodiak Capital Group, LLC. Kodiak is an institutional investor headquartered in Newport Beach, California. The funding will provide working capital for operations, to develop the DME infrastructure, acquire DME businesses, and to retire some of FullCircle Registry’s debt, as defined in the Registration Statement.
FullCircle Registry Chief Executive Officer, Mr. Norman L. Frohreich, said in December, "I am very pleased to have this facility in place as it offers FullCircle access to additional funds that may be required for working capital and to begin the acquisition of Durable Medical Equipment businesses (DMEs) in Louisiana and South Carolina. FullCircle has been searching for funding to proceed with its acquisition business model for some time. Over the last year FullCircle has issued Letters of Intent to purchase several medical supply businesses, using stock, notes and cash. The negotiations involving these acquisitions are contingent on securing capital.”
Recently, FullCircle Registry announced that the showing of "The Interview" at its Georgetown 14 Cinemas theater received a strong response from patrons and media. All of the major media affiliates in Indianapolis, including Fox, NBC, CBS, and ABC provided television coverage of this exclusive theatrical showing of the movie, after Sony decided to release to approximately 330 selected theaters nationwide.
FullCircle Registry, Inc. (FLCR), closed Friday's trading session at $0.008, up 35.59%, on 639,419 volume with 8 trades. The average volume for the last 60 days is 378,042 and the stock's 52-week low/high is $0.0035/$0.07.
Spindle, Inc. (SPDL)
We are highlighting Spindle, Inc. (SPDL) today, here at the QualityStocks Daily Newsletter.
OTCQB-listed Spindle, Inc. is a foremost provider of mobile commerce solutions. Its solutions are for financial services providers and consumer-facing merchants of all sizes. Spindle is concentrating on pioneering new ways for businesses to quickly integrate mobile payments acceptance and mobile marketing services while empowering location-based merchant discovery, fulfillment and frictionless mobile payments for consumers. Spindle has its headquarters in Scottsdale, Arizona. The Company also has offices in Texas, Florida, Colorado and Utah.
Spindle delivers its products as a standalone solution or in tandem with existing payment, acquiring, and acceptance offerings to create a strong, multi-functional mobile commerce ecosystem. The Company has a broad proprietary intellectual property (IP) portfolio (includes patents pending), which cover networks, mobile payments, and security. Spindle’s commitment is to expanding beyond traditional electronic payment boundaries through offering leading-edge solutions that allow clients, partners, merchants, and consumers to take full advantage of the fast developing mobile economy.
Spindle’s Merchant Solutions include Mobile Merchant Platforms, Cloud POS Solutions, eCommerce Payment Solutions, and Check Services (ACH & Check Imaging). Its Consumer Solutions include Mobile Wallet, and Loyalty, Offers and Couponing. Its Managed Services include PSP/PF Servicing, Payments Infrastructure, and Cloud POS Integration.
Spindle’s MeNetwork360(SM) application is available to merchants and consumers. The MeNetwork360 app combines location-based mobile marketing and payment processing on a single platform. The MeNetwork360 app is compatible with iOS and Android devices. MeNetwork360's smartphone and tablet app offers a wide array of mobile marketing functionalities, featuring a merchant-facing and a consumer-facing interface within the same intuitively designed application.
Spindle acquired Yowza!!, which is a provider of mobile couponing technology. This technology, integrated with Spindle's MeNetwork platform, gave Spindle in 2014 an increase in merchant locations to 95,000 through the combined service.
Spindle has signed distribution agreements with a broad spectrum of channel partners. These include MMIT/Offwire, Signifi, and Merchant Plus. Via these relationships, the Company can offer complete mobile commerce services through multiple channels. These channels include wireless providers, vending services operators, and technology solutions providers.
Last week, Spindle announced that it signed an agreement with payment processing industry consulting firm Transaction Data USA, Inc. (TD USA). This agreement is to resell Spindle's payment aggregation services and its’ Yowza!! Offers mobile marketing services. TD USA recently completed integration of Spindle's gateway platform, making these services open for general availability.
Spindle, Inc. (SPDL), closed Friday's trading session at $0.64, up 6.67%, on 20,100 volume with 10 trades. The average volume for the last 60 days is 7,468 and the stock's 52-week low/high is $0.465/$3.05.
Security Devices International, Inc. (SDEV)
Nebula Stocks reported previously on Security Devices International, Inc. (SDEV), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Founded in 2005, Security Devices International (SDI), Inc. is a defense technology company based in Tampa, Florida. The Company specializes in the sale of innovative, next generation non-lethal ammunition. Currently, SDI is deploying its family of non-lethal ammunition to foreign militaries, law enforcement, correctional services, as well as homeland security agencies around the world. SDI lists on the OTC Market Group’s OTCQB.
SDI is in the market-entry phase of deploying its family of non-lethal ammunition to global military law enforcement and correctional agencies. SDI rounds have undergone development to be used at longer ranges to ensure safety of the user and provide an effective means to incapacitate subjects without causing lethal injury.
SDI’s solutions are a safer alternative to conventional crowd control devices presently in the marketplace, including bean-bags, batons, and plastic and rubber bullets. Its products include the BIP (Blunt Impact Projectile), its full line of payload ammunition, and the WEP (Wireless Electric Projectile). The BIP and WEP line of ammunitions incorporate a unique collapsible head for kinetic energy mitigation that makes it highly effective even at very close range.
The BIP’s collapsible head allows for more surface contact, and thus greater pain compliance. SDI’s WEP uses mini harpoons to affix the bullet to the target’s clothing and body. WEP releases a charge, electro-neural muscular impulse. It is a customized product for a specialty market.
This past October, Security Devices International (SDI) announced that the Company and a division of Abrams Airborne Manufacturing Inc. (AAMI), namely Milkor USA (MUSA), agreed to partner for a joint cross-selling/marketing initiative. This arrangement permits both companies to take advantage of existing and future sales channels through offering a comprehensive, full-package of Milkor USA’s 40mm Multi-Shot Grenade Launchers in union with SDI’s 40mm Less-Lethal ammunition product-line to end-users worldwide. Milkor USA is the world’s premier provider of 40mm Multi-Shot Grenade Launchers (MSGL).
Security Devices International, Inc. (SDEV), closed Friday's trading session at $0.25, down 10.71%, on 125,000 volume with 26 trades. The average volume for the last 60 days is 12,511 and the stock's 52-week low/high is $0.143/$0.50.
Terra Tech Corp. (TRTC)
SmallCapVoice, Top Stock Picks, Market Authority, Penny Stocks24, Penny Stock, and Center Stage Stocks reported on Terra Tech Corp. (TRTC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Terra Tech Corp., through its wholly-owned subsidiary GrowOp Technology, specializes in controlled environment agricultural technologies. Terra Tech integrates best-of-breed hydroponic equipment with proprietary software and hardware to provide sustainable solutions for indoor agriculture enterprises and home practitioners. It works closely with expert horticulturists, engineers, and plant scientists to develop and manufacture advanced proprietary products for the emerging urban agricultural industry and individual hobbyists. The Company operates in two distinct markets. One is Commercial Agriculture; the other is Retail Agriculture.
Concerning Retail Agriculture, Terra Tech, by way of GrowOp Technology, designs and manufactures an advanced and affordable line of horticulture equipment. GrowOp Technology operates out of its warehouse facility in Oakland, California.
Regarding Commercial Agriculture, Terra Tech works with customers to help design, develop, and manufacture cultivation systems that maximize space and reduce energy costs. It offers rooftop/vertical hydroponic and aeroponic systems to custom designed greenhouse management systems.
Moreover, Terra Tech centers on medical cannabis cultivation technology. Its products include Commercial Hydroponic and Aeroponic Systems with 'ADS' Automated Dosing Systems; Digital Atmospheric Controllers: Lighting, Humidity, C02 and more, and Commercial Greenhouse Manufacturing.
Terra Tech cultivates a premier brand of local and sustainably grown hydroponic produce through its wholly-owned subsidiary Edible Garden. This produce sells through leading grocery stores throughout Massachusetts, New Hampshire, New Jersey, New York, Delaware, Maryland, Connecticut, Pennsylvania, Maine, Indiana, and Ohio.
Terra Tech announced in August 2014 that its subsidiaries MediFarm, MediFarm I and MediFarm II submitted applications to operate Medical Marijuana Enterprises (MME) to the state of Nevada. Terra Tech has already received a special use permit for a cultivation and production facility in Clark County, Nevada. It also submitted its applications for a special use permit and compliance permit to the City of Las Vegas, Nevada.
MediFarm, MediFarm I, and MediFarm II have all received provisional certificates from the State of Nevada in each local jurisdiction where they applied for a Medical Marijuana Establishment license. Together, these subsidiaries were issued four Dispensary provisional certificates, 2 Cultivation provisional certificates, and 2 Production provisional certificates spanning Northern and Southern Nevada.
Earlier this month, Terra Tech subsidiary Edible Garden announced a new line of organic living produce. It received organic certification, from Baystate Organic Certifiers, for its line of 4" potted herbs. Baystate is a USDA National Organic Program accredited certifying agent. Baystate certifies farm operations in the Northeast & Mid-Atlantic United States. Edible Garden is pursuing additional retail partners to fill out its new 5-acre facility and the facilities of its cultivation partners in Florida and the Midwest.
Terra Tech Corp. (TRTC), closed Friday's trading session at $0.23131, up 0.13%, on 770,688 volume with 213 trades. The average volume for the last 60 days is 1,641,459 and the stock's 52-week low/high is $0.21/$1.42.
EastGate Biotech Corp. (ETBI)
Today we are highlighting EastGate Biotech Corp. (ETBI), here at the QualityStocks Daily Newsletter.
EastGate Biotech Corp. is an emerging pharmaceutical company listed on the OTCQB. It is exploring drug delivery innovations for the development of novel formulations and alternative dosage forms of existing biologically active molecules. The Company’s research and development scientists have over 60 years of combined experience. EastGate Biotech is headquartered in North York, Ontario.
Regarding its technologies, the Company develops products in which the active components are incorporated into vehicles containing nano-sized delivery vectors. These include oil droplets (nanoemulsions), polymeric particles (nanoparticles), and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles).
EastGate Biotech’s products include E-Drops. This product has been used to effectively combat urinary and vaginal tract infections. The plant essential oils of E-drops contain antibacterial and antiseptic properties. The Company’s products also include Essential D, and Puralen (an all-natural herbal cleanse of colon and the urinary tract).
Additionally, products include GluCorrect. GluCorrect soft gelatin capsules improve energy supply and prevent fat formation from excessive amounts of sugar. The Company’s products also include VCleanzz (an antibacterial wash for fruits and vegetables), Cleanezze (a natural hand sanitizer), and Warts X (a natural herbal product for treating warts).
Glucora is an addition to a line of natural products developed at EastGate Biotech. Glucora is a natural based formula in a self-emulsifying delivery system, which provides support for healthy glucose metabolism.
Today, EastGate Biotech announced that it received an NPN (Natural Product Number) from the Natural and Non-Prescription Health Products Directorate of Health Canada for its natural product Glucora.
Ms. Anna Gluskin, EastGate Biotech’s Chief Executive Officer, said, "We are pleased with the addition of NPN license for our product Glucora. Both the nutraceutical and pharmaceutical industries are consistently looking out for innovative products in the area of glucose metabolism regulation that improve patient compliance, since the consumer demand in diabetes management is growing."
EastGate Biotech Corp. (ETBI), closed Friday's trading session at $0.037, up 6.63%, on 1,330,748 volume with 88 trades. The average volume for the last 60 days is 42,530 and the stock's 52-week low/high is $0.0295/$0.65.
First Choice Healthcare Solutions, Inc. (FCHS)
Greenbackers, TheMicrocapNews, PennyStockSpy, 007 Stock Chat, StocksImpossible, First Penny Picks and OTCBB Journal reported earlier on First Choice Healthcare Solutions, Inc. (FCHS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
First Choice Healthcare Solutions, Inc. (FCHS) engages in owning and operating multi-specialty medical centers of excellence throughout the southeastern United States. The Company’s commitment is to delivering clinically superior, patient-centric care. It operates its different businesses through its wholly-owned subsidiaries, FCID Medical, Inc. and FCID Holdings, Inc. FCHS’s shares trade on the OTC Market Group’s OTCQB. The Company has its corporate office in Melbourne, Florida.
FCID Medical acquired First Choice Medical Group of Brevard, LLC. First Choice Medical Group is a multispecialty medical group specializing in Orthopedics, Neurology, and Pain Management. By way of FCID Medical, the Company operates its flagship center, First Choice Medical Group, which specializes in the delivery of musculoskeletal medicine and rehabilitative care. FCHS' commercial real estate interests, which house its medical centers of excellence, are managed by FCID Holdings.
The foundation of the FCID Medical business plan is to develop and acquire efficient, specialized healthcare clinical units. The professional medical clinical units include an optimum mix of synergistic multi-specialty physicians combined with a variety of diagnostic capabilities.
Regarding FCHS’ Real Estate Division facilities, it has its Marina Towers, LLC. Marina Towers is a Class A, 68,000 sq. ft., five story office building on the Indian River in Melbourne, Florida. This building is home to tenants such as UBS Financial, Support Systems and Modus Operandi. The building is also home to First Choice Medical Group.
Concerning its medical centers of excellence, the Company indicates that each Center is and shall be limited to 10 complementary specialty physicians; structured to provide for the combination of synergistic medical disciplines and is supported by related in-house diagnostic services and technologies; can generate up to $16-$20 million when operating at full capacity; and housed in a commercial building, in close geographic proximity to a primary hospital(s), and allows for 12,000-16,000 square feet of usable space for build-out consideration.
First Choice Healthcare Solutions, Inc. (FCHS), closed Friday's trading session at $1.06, up 2.91%, on 15,814 volume with 35 trades. The average volume for the last 60 days is 14,811 and the stock's 52-week low/high is $0.54/$3.70.
Save The World Air, Inc. (ZERO)
The QualityStocks Daily Newsletter would like to spotlight Save The World Air, Inc. (ZERO). Today, Save The World Air, Inc. closed trading at $0.4172, off by 7.70%, on 128,370 volume with 48 trades. The stock’s average daily volume over the past 60 days is 104,465, and its 52-week low/high is $0.3401/$1.10.
Save The World Air, Inc. (ZERO) (“STWA”) provides the global energy industry with patent-protected industrial equipment designed to deliver measurable performance improvements to crude oil pipelines. Developed in partnership with leading crude oil production and transportation entities, STWA’s high-value solutions address the enormous capacity inadequacies of domestic and overseas pipeline infrastructures that were designed and constructed prior to the current worldwide surge in oil production.
In support of our clients’ commitment to the responsible sourcing of energy and environmental stewardship, STWA combines scientific research with inventive problem solving to provide energy efficiency ‘clean tech’ solutions to bring new efficiencies and lower operational costs to the upstream, midstream and gathering sectors. STWA’s flagship product, AOT (Applied Oil Technology) improves the economics of transporting crude oil by reducing the viscosity of oil in pipelines. Once deployed on pipeline pumping stations, production and transportation companies benefit from the safer, more cost-effective delivery of greater volumes of oil while reducing energy consumption at pumping stations and lowering CO2 emissions.
The AOT technology is the result of years of research conducted at Temple University (Philadelphia, Penn.) and is the world’s first ASME-certified industrial hardware to use the principles of electrorheology, the study of applying non-uniform electrical fields to change the mechanical behavior of fluids, to significantly reduce the viscosity of crude oil within pipelines during maximum flow conditions. Field tested by the U.S. Department of Energy, independent testing laboratories such as ATS RheoSystems and fabricated to exacting industry standards by STWA’s supply chain partners, the efficacy of AOT to increase flow rates, prevent bottlenecks, reduce pump station power consumption, enhance pipeline integrity and optimize flow assurance has been proven repeatedly in the lab and on a 300,000 barrel per day pipeline.
STWA is also commercializing STWA Joule Heat, an energy-efficient technology for heating crude oil in pipelines to improve flow. Unlike traditional trace heating systems which generate heat via a resistive trace heating element which transfers energy into the oil, the STWA solution applies an electrical field directly to oil, generating heat within the flow itself. The result is optimal heat conductivity and performance with less power and in a smaller form factor.
Guided by a dynamic management team led by Greggory Bigger, Chief Executive Officer, Chairman and a strong independent board of directors of energy industry veterans, STWA is a revenue generating company with a solid cash position, clean balance sheet and a proven ability to develop and deliver industrial-grade equipment that support the company’s mission and enhance shareholder value. As the exclusive licensee of oil viscosity reduction processes developed at Temple University and owner of 48 worldwide patents related to the use of electricity to change the mechanical behavior of oil and liquid natural gas, STWA is well-positioned to capitalize on the explosive growth opportunities in the global crude oil production and transportation sector. More information is available at: www.stwa.com. Disclaimer
Save The World Air, Inc. Company Blog
Save The World Air, Inc. News:
STWA Issues Letter to Shareholders
STWA Upgrades to OTCQX(R) Marketplace
OTC Markets Group Welcomes Save The World Air to OTCQX®OTC Markets Group Welcomes Save The World Air to OTCQX®
One World Holdings, Inc. (OWOO)
The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0033, up 43.48%, on 2,988,351 volume with 90 trades. The stock’s average daily volume over the past 60 days is 3,923,823, and its 52-week low/high is $0.0008/$0.71.
One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.
In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.
The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.
Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer
One World Holdings, Inc. Company Blog
One World Holdings, Inc. News:
Vivica A. Fox Talks About Her Collaboration With The One World Doll Project
The One World Doll Project to Release Collectors Doll With Vivica A. Fox
The One World Doll Project Expands Retail Presence in Texas With Fiesta Mart
Pure Hospitality Solutions, Inc. (PNOW)
The QualityStocks Daily Newsletter would like to spotlight Pure Hospitality Solutions, Inc. (PNOW). Today, Pure Hospitality Solutions, Inc. closed trading at $0.022, up 35.80%, on 51,780 volume with 13 trades. The stock’s average daily volume over the past 60 days is 67,031, and its 52-week low/high is $0.0031/$0.9412.
Pure Hospitality Solutions, Inc. (PNOW) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.
The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Pure continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.
Operating a successful bi-lateral business model, Pure has four objectives:
1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;
2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;
3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,
4. Expand the portfolio of Pure-owned boutique hotels operating under the Hotel PURE brand.
The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.
Ultimately, Pure intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer
Pure Hospitality Solutions, Inc. Company Blog
Pure Hospitality Solutions, Inc. News:
PURE Hospitality Solutions Launches Non-Toxic Funding Campaign for Oveedia
PURE Hospitality Solutions Retains StartX Software Consulting; Oveedia Interactive Infrastructure
PURE Hospitality Solutions Releases FROL Case Study; Establishing Viability of Central American-Caribbean Launch of Oveedia
Puget Technologies (PUGE)
The QualityStocks Daily Newsletter would like to spotlight Puget Technologies (PUGE). Today, Puget Technologies closed trading at $0.13, up 20.93%, on 332,300 volume with 77 trades. The stock’s average daily volume over the past 60 days is 77,650, and its 52-week low/high is $0.013/$0.84.
Puget Technologies (PUGE) is primarily focused on the development and marketing of leading-edge technologies via acquisition of companies that are highly profitable or have the potential to be highly profitable in the near future. The company will target opportunities that offer consumer cost savings, energy savings, better health, and cleaner air, water, and earth.
Puget Technologies is specifically searching for companies that have proof of concept, key management in place, and a product that is ready for the market or in preparation for launch. The company will perform due diligence on the opportunities identified to determine the elements necessary to fully fund and exploit future revenue streams and asset appreciation as a public entity.
Companies acquired by Puget Technologies will gain services and products for marketing solutions as well as a platform to enter the public markets. The focus of this business model is to help private companies move forward in the market with their solutions without having to depend on funds from family and friends, venture capital or investment banking firms for necessary capital.
The growth strategy employed by Puget Technologies is designed to reduce risk exposure and leverage multiple streams of revenue. This approach is expected to lead to greater cash flows, complement the asset base, and enhance revenues in concert with minimal capital investment to gain even greater efficiency while also enhancing startup funding timelines. Disclaimer
Puget Technologies Company Blog
Puget Technologies News:
Puget Technologies Forms Strategic Alliance With RamRock Building Systems
Puget Technologies Moves Company Headquarters to Englewood, CO
Puget Completes Shipping of First Orders of 3D Printers
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.0023, up 15.00%, on 10,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 56,327, and its 52-week low/high is $0.0016/$0.018.
Consorteum Holdings, Inc. (CSRH) has spent the last 3 years developing relationships and licensing agreements to take the center stage in the emerging market of mobile gaming. The company has the capability to deliver rich mobile content to end users who will use their smart phones in ways that could not even have been imagined five years ago.
Specializing in delivery of mobile content, mobile payment solutions and products through a mix of on-deck partnerships, license agreements, and joint venture revenue share arrangements, the company operates as a technology and services aggregator to meet the diverse needs of its client base. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
ThreeFiftyNine Inc., a wholly owned subsidiary, hired a software development team that had previously designed the world’s first regulatory compliant mobile platform for delivery of gaming content created by a third party. The platform, which has met the rigorous standards of the Nevada Gaming Board, the gold standard in regulatory gaming, represents the first generation software delivery platform for mobile devices. The development team spent the past 5 years and millions of dollars in non-recurring engineering costs to complete the development of the platform. At the heart is the capability to deliver any digital content across any cellular network to any mobile device. This key differentiator makes it possible for Consorteum to approach many different markets that are in the business of providing mobile connectivity and mobile content.
Consorteum’s mobile initiatives will benefit multiple business verticals. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Signs License Agreement With NYG Holdings
Consorteum Holdings Signs Mobile Application Development Contract With Bet Butler Limited
Consorteum Holdings Launches New Mobile Results App for Popular Keno Game
Zenosense, Inc. (ZENO)
The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.22, up 4.79%, on 39,102 volume with 12 trades. The stock’s average daily volume over the past 60 days is 152,511, and its 52-week low/high is $0.15/$1.00.
Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.
Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.
The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.
Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.
Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer
Zenosense, Inc. Company Blog
Zenosense, Inc. News:
Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial
Zenosense, Inc.; Stock Now DTC DWAC/FAST Eligible
Zenosense, Inc. Reports Manufacturing of Pre-Commercial Lung Cancer Detection Device
Dominovas Energy Corp. (DNRG)
The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.30, even for the day. The stock’s average daily volume over the past 60 days is 3,191 and its 52-week low/high is $0.06/$0.60.
Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.
At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.
In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.
Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer
Dominovas Energy Corp. Blog
Dominovas Energy Corp. News:
Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
Dominovas Energy Corp. Appoints International Business Professional to Board of Directors
Dominovas Energy and Delphi Sign MOU
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Boreal Water Collection, Inc. (BRWC) to Exhibit at China's Largest Food Show
- Cleartronic, Inc. (CLRI) Appoints Two New Members to Board of Directors
- Coastal Integrated Services, Inc. (COLV) Announces Engagement of QualityStocks Investor Relations Services
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
- Falcon Crest Energy (FCEN) Optimistic About Prospecting in Powder River Basin
- IFAN Financial, Inc. (IFAN) Enters Agreement to Provide Development Assistance to Card Collaborative International, LLC
- MIT Holding, Inc. (MITD) Names Tommy J. Duncan as President
- Mobile Lads Corp. (MOBO) Purchases Majority of North American Shopping Network From Domark International
- One World Holdings, Inc. (OWOO) Vivica A. Fox Talks About Her Collaboration With The One World Doll Project
- Pan Global Corp. (PGLO) Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017
- Puget Technologies, Inc. (PUGE) Forms Strategic Alliance With RamRock Building Systems
- Pure Hospitality Solutions, Inc. (PNOW) Launches Non-Toxic Funding Campaign for Oveedia
- Save The World Air, Inc. (ZERO) Issues Letter to Shareholders
- Sibling Group Holdings, Inc. (SIBE) Interviewed by TheStockRadio.com
- Sparta Commercial Services, Inc. (SRCO) iMobileApp's Customer Base Continues to Grow and Broaden
- Start Scientific, Inc. (STSC) Signs Farmout Agreement With Durban Energy
- VistaGen Therapeutics, Inc. (VSTA) Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) to host second webinar on proprietory micro-refinery technology
- WordLogic Corp. (WLGC) Inks Deal to Monetize Intellectual Property for General Electric (GE)
- Zenosense, Inc. (ZENO) Hospital Collaboration - 400 Person Lung Cancer Detection Trial